Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation

Veronica Huber, Chiara Camisaschi, Angela Berzi, Simona Ferro, Luana Lugini, Tiziana Triulzi, Alessandra Tuccitto, Elda Tagliabue, Chiara Castelli, Licia Rivoltini

Research output: Contribution to journalReview article

Abstract

The link between cancer metabolism and immunosuppression, inflammation and immune escape has generated major interest in investigating the effects of low pH on tumor immunity. Indeed, microenvironmental acidity may differentially impact on diverse components of tumor immune surveillance, eventually contributing to immune escape and cancer progression. Although the molecular pathways underlying acidity-related immune dysfunctions are just emerging, initial evidence indicates that antitumor effectors such as T and NK cells tend to lose their function and undergo a state of mostly reversible anergy followed by apoptosis, when exposed to low pH environment. At opposite, immunosuppressive components such as myeloid cells and regulatory T cells are engaged by tumor acidity to sustain tumor growth while blocking antitumor immune responses. Local acidity could also profoundly influence bioactivity and distribution of antibodies, thus potentially interfering with the clinical efficacy of therapeutic antibodies including immune checkpoint inhibitors. Hence tumor acidity is a central regulator of cancer immunity that orchestrates both local and systemic immunosuppression and that may offer a broad panel of therapeutic targets. This review outlines the fundamental pathways of acidity-driven immune dysfunctions and sheds light on the potential strategies that could be envisaged to potentiate immune-mediated tumor control in cancer patients.

Original languageEnglish
Pages (from-to)74-89
Number of pages16
JournalSeminars in Cancer Biology
Volume43
DOIs
Publication statusPublished - Apr 1 2017

Fingerprint

Tumor Escape
Immunomodulation
Neoplasms
Immunosuppression
Immunity
Antibodies
Regulatory T-Lymphocytes
Myeloid Cells
Immunosuppressive Agents
Natural Killer Cells
Apoptosis

Keywords

  • Acidity
  • Cancer
  • Glycolysis
  • Hypoxia
  • Immune checkpoints
  • Immunity
  • Immunosurveillance
  • Immunotherapy
  • Lactate
  • Myeloid-derived suppressor cells
  • pH
  • Regulatory T cells
  • Therapeutic antibodies
  • Tumor microenvironment

ASJC Scopus subject areas

  • Cancer Research

Cite this

Cancer acidity : An ultimate frontier of tumor immune escape and a novel target of immunomodulation. / Huber, Veronica; Camisaschi, Chiara; Berzi, Angela; Ferro, Simona; Lugini, Luana; Triulzi, Tiziana; Tuccitto, Alessandra; Tagliabue, Elda; Castelli, Chiara; Rivoltini, Licia.

In: Seminars in Cancer Biology, Vol. 43, 01.04.2017, p. 74-89.

Research output: Contribution to journalReview article

Huber, Veronica ; Camisaschi, Chiara ; Berzi, Angela ; Ferro, Simona ; Lugini, Luana ; Triulzi, Tiziana ; Tuccitto, Alessandra ; Tagliabue, Elda ; Castelli, Chiara ; Rivoltini, Licia. / Cancer acidity : An ultimate frontier of tumor immune escape and a novel target of immunomodulation. In: Seminars in Cancer Biology. 2017 ; Vol. 43. pp. 74-89.
@article{816d3fa1cfcd45188d8154fe7ec28c36,
title = "Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation",
abstract = "The link between cancer metabolism and immunosuppression, inflammation and immune escape has generated major interest in investigating the effects of low pH on tumor immunity. Indeed, microenvironmental acidity may differentially impact on diverse components of tumor immune surveillance, eventually contributing to immune escape and cancer progression. Although the molecular pathways underlying acidity-related immune dysfunctions are just emerging, initial evidence indicates that antitumor effectors such as T and NK cells tend to lose their function and undergo a state of mostly reversible anergy followed by apoptosis, when exposed to low pH environment. At opposite, immunosuppressive components such as myeloid cells and regulatory T cells are engaged by tumor acidity to sustain tumor growth while blocking antitumor immune responses. Local acidity could also profoundly influence bioactivity and distribution of antibodies, thus potentially interfering with the clinical efficacy of therapeutic antibodies including immune checkpoint inhibitors. Hence tumor acidity is a central regulator of cancer immunity that orchestrates both local and systemic immunosuppression and that may offer a broad panel of therapeutic targets. This review outlines the fundamental pathways of acidity-driven immune dysfunctions and sheds light on the potential strategies that could be envisaged to potentiate immune-mediated tumor control in cancer patients.",
keywords = "Acidity, Cancer, Glycolysis, Hypoxia, Immune checkpoints, Immunity, Immunosurveillance, Immunotherapy, Lactate, Myeloid-derived suppressor cells, pH, Regulatory T cells, Therapeutic antibodies, Tumor microenvironment",
author = "Veronica Huber and Chiara Camisaschi and Angela Berzi and Simona Ferro and Luana Lugini and Tiziana Triulzi and Alessandra Tuccitto and Elda Tagliabue and Chiara Castelli and Licia Rivoltini",
year = "2017",
month = "4",
day = "1",
doi = "10.1016/j.semcancer.2017.03.001",
language = "English",
volume = "43",
pages = "74--89",
journal = "Seminars in Cancer Biology",
issn = "1044-579X",
publisher = "Academic Press",

}

TY - JOUR

T1 - Cancer acidity

T2 - An ultimate frontier of tumor immune escape and a novel target of immunomodulation

AU - Huber, Veronica

AU - Camisaschi, Chiara

AU - Berzi, Angela

AU - Ferro, Simona

AU - Lugini, Luana

AU - Triulzi, Tiziana

AU - Tuccitto, Alessandra

AU - Tagliabue, Elda

AU - Castelli, Chiara

AU - Rivoltini, Licia

PY - 2017/4/1

Y1 - 2017/4/1

N2 - The link between cancer metabolism and immunosuppression, inflammation and immune escape has generated major interest in investigating the effects of low pH on tumor immunity. Indeed, microenvironmental acidity may differentially impact on diverse components of tumor immune surveillance, eventually contributing to immune escape and cancer progression. Although the molecular pathways underlying acidity-related immune dysfunctions are just emerging, initial evidence indicates that antitumor effectors such as T and NK cells tend to lose their function and undergo a state of mostly reversible anergy followed by apoptosis, when exposed to low pH environment. At opposite, immunosuppressive components such as myeloid cells and regulatory T cells are engaged by tumor acidity to sustain tumor growth while blocking antitumor immune responses. Local acidity could also profoundly influence bioactivity and distribution of antibodies, thus potentially interfering with the clinical efficacy of therapeutic antibodies including immune checkpoint inhibitors. Hence tumor acidity is a central regulator of cancer immunity that orchestrates both local and systemic immunosuppression and that may offer a broad panel of therapeutic targets. This review outlines the fundamental pathways of acidity-driven immune dysfunctions and sheds light on the potential strategies that could be envisaged to potentiate immune-mediated tumor control in cancer patients.

AB - The link between cancer metabolism and immunosuppression, inflammation and immune escape has generated major interest in investigating the effects of low pH on tumor immunity. Indeed, microenvironmental acidity may differentially impact on diverse components of tumor immune surveillance, eventually contributing to immune escape and cancer progression. Although the molecular pathways underlying acidity-related immune dysfunctions are just emerging, initial evidence indicates that antitumor effectors such as T and NK cells tend to lose their function and undergo a state of mostly reversible anergy followed by apoptosis, when exposed to low pH environment. At opposite, immunosuppressive components such as myeloid cells and regulatory T cells are engaged by tumor acidity to sustain tumor growth while blocking antitumor immune responses. Local acidity could also profoundly influence bioactivity and distribution of antibodies, thus potentially interfering with the clinical efficacy of therapeutic antibodies including immune checkpoint inhibitors. Hence tumor acidity is a central regulator of cancer immunity that orchestrates both local and systemic immunosuppression and that may offer a broad panel of therapeutic targets. This review outlines the fundamental pathways of acidity-driven immune dysfunctions and sheds light on the potential strategies that could be envisaged to potentiate immune-mediated tumor control in cancer patients.

KW - Acidity

KW - Cancer

KW - Glycolysis

KW - Hypoxia

KW - Immune checkpoints

KW - Immunity

KW - Immunosurveillance

KW - Immunotherapy

KW - Lactate

KW - Myeloid-derived suppressor cells

KW - pH

KW - Regulatory T cells

KW - Therapeutic antibodies

KW - Tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=85015854004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015854004&partnerID=8YFLogxK

U2 - 10.1016/j.semcancer.2017.03.001

DO - 10.1016/j.semcancer.2017.03.001

M3 - Review article

AN - SCOPUS:85015854004

VL - 43

SP - 74

EP - 89

JO - Seminars in Cancer Biology

JF - Seminars in Cancer Biology

SN - 1044-579X

ER -